arginase 1
Zuletzt aktualisiert 14. Feb 2024
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
The ARG1 gene provides instructions for producing the enzyme arginase. This enzyme participates in the urea cycle, a series of reactions that occurs in liver cells. The urea cycle processes excess nitrogen, which is generated when proteins and their building blocks (amino acids) are used by the body. The urea cycle produces a compound called urea from excess nitrogen. Urea is then excreted by the kidneys. Excreting the excess nitrogen prevents it from accumulating in the form of ammonia, which is toxic.
Normal function
The ARG1 gene provides instructions for producing the enzyme arginase. This enzyme participates in the urea cycle, a series of reactions that occurs in liver cells. The urea cycle processes excess nitrogen, which is generated when proteins and their building blocks (amino acids) are used by the body. The urea cycle produces a compound called urea from excess nitrogen. Urea is then excreted by the kidneys. Excreting the excess nitrogen prevents it from accumulating in the form of ammonia, which is toxic.
Arginase facilitates the last step of the urea cycle, a reaction in which nitrogen is removed from the amino acid arginine and processed into urea. A compound called ornithine is also produced during this reaction; it is needed for the urea cycle to repeat.
Conditions referring to this gene or chromosome
Other names
A-I
ARGI1_HUMAN
arginase, liver
arginase, type I
Related patient information and medicines

Patient information leaflet
Impfung gegen Grippe
All viruses have evolved to try and increase their own numbers constantly by infe... Expert scientists and the World Health Organization (WHO) monitor Grippe viruses throughout the world and predict which flu strains they think are going to be the die meisten active each year and therefore which strains are to be included in the current year's vaccine. This.

Patient information leaflet
Pneumokokken-Immunisierung
Pneumococcus can cause diseases such as pneumonia, meningitis and blood infections. Children aged under 2 years should receive the vaccine. Examples include chronic bronchitis, emphysema, Chronic obstructive pulmonary disease cystic fibrosis Cystic fibrosis and severe asthma Asthma (needing re... Have a chronic heart disease. Examples include.

Patient information leaflet
5:2 Diät
The 5:2 diet is a calorie-restricted diet that involves eating 'normally' for five days out of seven and then 'fasting' on the other two days out of seven. The theory is that the fasting days lower the levels of a certain chemical in the body known as insulin-like growth factor 1 (IGF-1). It is thought that high levels von IGF-1 in the body.

Patient information leaflet
Vorhofflimmern und Schlaganfallprävention
The medicines used to prevent a atrial fibrillation-related stroke are called anticoagulants. These help to stop blood clots forming in your blood vessels. D iabet... Past history of a S troke or transient ischaemic attack Transient ischaemic attack (2 points). V ascular disease - for example, peripheral arterial disease Peripher arterial.

Patient information leaflet
Nierensteine
Nierensteine sind hard stones that can cause severe pain in your side along with blood in your urine, and nausea and vomiting. You are more likely to develop kidney stones if you eat a Western diet, don't drink enough fluids or are overweight. Once you have had one episode they are likely to recur but there are several kidney stone treatment.

Patient information leaflet
Telogenes Effluvium
Telogen effluvium (hair loss) is a condition where more than normal amounts of hair fall out. There is a general 'thinning' of the hair. Unlike some other hair and scalp conditions, it is temporary and the hair growth usually recovers. What is telogen effluvium. Telogen effluvium is rapid hair loss that is caused by stress or a change to your.
Weiterführende Lektüre und Referenzen
- arginase 1; MedlinePlus, National Library of Medicine.
- Iyer R, Jenkinson CP, Vockley JG, Kern RM, Grody WW, Cederbaum S. The human arginases and arginase deficiency. J Inherit Metab Dis. 1998;21 Suppl 1:86-100. doi: 10.1023/a:1005313809037.
- Iyer RK, Yoo PK, Kern RM, Rozengurt N, Tsoa R, O'Brien WE, Yu H, Grody WW, Cederbaum SD. Mouse model for human arginase deficiency. Mol Cell Biol. 2002 Jul;22(13):4491-8. doi: 10.1128/MCB.22.13.4491-4498.2002.
- Vockley JG, Goodman BK, Tabor DE, Kern RM, Jenkinson CP, Grody WW, Cederbaum SD. Loss of function mutations in conserved regions of the human arginase I gene. Biochem Mol Med. 1996 Oct;59(1):44-51. doi: 10.1006/bmme.1996.0063.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
14. Feb 2024 | Neueste Version
1. Feb 2024 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

